N-trimethyl chitosan-modified liposomes as carriers for oral delivery of salmon calcitonin

Drug Delivery

Volumn 18, Issue 8, 2011, Pages 562-569

  Huang, Aiwen ^a,b   Makhlof, Abdallah ^b   Ping, Qineng ^a   Tozuka, Yuichi ^b   Takeuchi, Hirofumi ^b  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Calcitonin; Liposomes; Mucoadhesive; Oral peptide delivery; Trimethyl chitosan

Indexed keywords

CALCIUM; CHITOSAN DERIVATIVE; LIPOSOME; MUCIN; N TRIMETHYL CHITOSAN; SALCATONIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CALCIUM BLOOD LEVEL; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG PENETRATION; FEASIBILITY STUDY; IN VITRO STUDY; IN VIVO STUDY; MALE; MEAN RESIDENCE TIME; MUCOADHESION; NONHUMAN; ORAL DRUG ADMINISTRATION; PARTICLE SIZE; PRIORITY JOURNAL; RAT; SYNTHESIS; ZETA POTENTIAL;

ADMINISTRATION, ORAL; ANIMALS; BLOOD; BONE DENSITY CONSERVATION AGENTS; CALCITONIN; CALCIUM; CHITOSAN; CHOLESTEROL; COUMARINS; DRUG CARRIERS; HYDROGEN-ION CONCENTRATION; INTESTINE, SMALL; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICROSCOPY, ATOMIC FORCE; MUCINS; ORGANOPHOSPHATES; PARTICLE SIZE; PHOSPHATIDYLCHOLINES; RATS; RATS, WISTAR; STATIC ELECTRICITY; SURFACE PROPERTIES; THIAZOLES; UNILAMELLAR LIPOSOMES;

EID: 82055197203     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2011.596585     Document Type: Article

References (26)

1. Amidi, M., Mastrobattista, E., Jiskoot, W., Hennink, W. E. (2010) Chitosan-based delivery systems for protein therapeutics and antigens. Adv Drug Deliv Rev, 62, 59-82.
2. Cheng, H. C., Chang, C. Y., Hsieh, F. I., Yeh, J. J., Chien, M. Y., Pan, R. N., Deng, M. C., Liu, D. Z. (2011) Effects of tremella-alginate-liposome encapsulation on oral delivery of inactivated H5N3 vaccine. J Microencapsul, 28, 55-61.
3. Iwanaga, K., Ono, H., Narioka, K., Morimoto, K., Kakemi, M., Yamashita, S., Nango, M., Oku, N. (1997) Oral delivery of insulin by using surface coating liposomes: Improvement of stability of insulin in GI tract International Journal of Pharmaceutics, 157, 8.
4. Jintapattanakit, A., Junyaprasert, V. B., Kissel, T. (2009) The role of mucoadhesion of trimethyl chitosan and PEGylated trimethyl chitosan nanocomplexes in insulin uptake. J Pharm Sci, 98, 4818-30.
5. Jonker-Venter, C., Snyman, D., Janse Van Rensburg, C., Jordaan, E., Schultz, C., Steenekamp, J. H., Hamman, J. H., Kotze, A. F. (2006) Low molecular weight quaternised chitosan (11): in vitro assessment of absorption enhancing properties. Pharmazie, 61, 301-5.
6. Jonker, C., Hamman, J. H., Kotze, A. F. (2002) Intestinal paracellular permeation enhancement with quaternised chitosan: in situ and in vitro evaluation. Int J Pharm, 238, 205-13. (Pubitemid 34457889)
7. Katas, H., Alpar, H. O. (2006) Development and characterisation of chitosan nanoparticles for siRNA delivery. J Control Release, 115, 216-25 (Pubitemid 44559708)
8. Kotze, A. F., Luessen, H. L., De Leeuw, B. J., De Boer, A. G., Verhoef, J. C., Junginger, H. E. (1998) Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2). J Control Release, 51, 35-46.
9. Kotze, A. F., Luessen, H. L., De Leeuw, B. J., De Boer, B. G., Verhoef, J. C., Junginger, H. E. (1997) N-trimethyl chitosan chloride as a potential absorption enhancer across mucosal surfaces: in vitro evaluation in intestinal epithelial cells (Caco-2). Pharm Res, 14, 1197-202. (Pubitemid 27432543)
10. Makhlof, A., Fujimoto, S., Tozuka, Y., Takeuchi, H. (XXXX) In vitro and in vivo evaluation of WGA-carbopol modified liposomes as carriers for oral peptide delivery. Eur J Pharm Biopharm.
11. Mao, S., Sun, W., Kissel, T. (2010) Chitosan-based formulations for delivery of DNA and siRNA. Adv Drug Deliv Rev, 62, 12-27.
12. Polnok, A., Borchard, G., Verhoef, J. C., Sarisuta, N., Junginger, H. E. (2004) Influence of methylation process on the degree of quaternization of N-trimethyl chitosan chloride. Eur J Pharm Biopharm, 57, 77-83. (Pubitemid 38058805)
13. Sieval, A. B., Thanou, M., Kotz, A. F., Verhoef, J. C., Brussee, J., Junginger, H. E. (1998) Preparation and NMR characterization of highly substituted N-trimethyl chitosan chloride. Carbohydr. Pollym, 36, 157-165. (Pubitemid 128399589)
14. Sinswat, P., Tengamnuay, P. (2003) Enhancing effect of chitosan on nasal absorption of salmon calcitonin in rats: comparison with hydroxypropyl-and dimethyl-beta-cyclodextrins. Int J Pharm, 257, 15-22. (Pubitemid 36507028)
15. Smart, J. D. (2005) The basics and underlying mechanisms of mucoadhesion. Adv Drug Deliv Rev, 57, 1556-68. (Pubitemid 41443469)
16. Takeuchi, H., Matsui, Y., Sugihara, H., Yamamoto, H. & Kawashima, Y. (2005a) Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs. Int J Pharm, 303, 160-70. (Pubitemid 41318033)
17. Takeuchi, H., Matsui, Y., Yamamoto, H., Kawashima, Y. (2003) Mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats. J Control Release, 86, 235-42. (Pubitemid 36084273)
18. Takeuchi, H., Thongborisute, J., Matsui, Y., Sugihara, H., Yamamoto, H., Kawashima, Y. (2005b) Novel mucoadhesion tests for polymers and polymer-coated particles to design optimal mucoadhesive drug delivery systems. Adv Drug Deliv Rev, 57, 1583-94. (Pubitemid 41443471)
19. Takeuchi, H., Yamamoto, H., Niwa, T., Hino, T. & Kawashima, Y. (1996) Enteral absorption of insulin in rats from mucoadhesive chitosan-coated liposomes. Pharm Res, 13, 896-901. (Pubitemid 26227747)
20. Thanou, M. M., Kotze, A. F., Scharringhausen, T., Luessen, H. L., De Boer, A. G., Verhoef, J. C., Junginger, H. E. (2000) Effect of degree of quaternization of N-trimethyl chitosan chloride for enhanced transport of hydrophilic compounds across intestinal caco-2 cell monolayers. J Control Release, 64, 15-25. (Pubitemid 30035304)
21. Thongborisute, J. & Takeuchi, H. (2008) Evaluation of mucoadhesiveness of polymers by BIACORE method and mucin-particle method. Int J Pharm, 354, 204-9.
22. Thongborisute, J., Tsuruta, A., Kawabata, Y., Takeuchi, H. (2006) The effect of particle structure of chitosan-coated liposomes and type of chitosan on oral delivery of calcitonin. J Drug Target, 14, 147-54. (Pubitemid 43878823)
23. Van Der Merwe, S. M., Verhoef, J. C., Verheijden, J. H., Kotze, A. F., Junginger, H. E. (2004) Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs. Eur J Pharm Biopharm, 58, 225-35. (Pubitemid 39037231)
24. Werle, M., Makhlof, A., Takeuchi, H. (2010) Carbopol-lectin conjugate coated liposomes for oral peptide delivery. Chem Pharm Bull (Tokyo), 58, 432-4.
25. Werle, M., Takeuchi, H. (2009) Chitosan-aprotinin coated liposomes for oral peptide delivery: Development, characterisation and in vivo evaluation. Int J Pharm, 370, 26-32.
26. Woodley, J. F. (1994) Enzymatic barriers for GI peptide and protein delivery. Crit Rev Ther Drug Carrier Syst, 11, 61-95.